Search results
Vertex (VRTX), TreeFrog Sign Deal for Diabetes Cell Therapies
Zacks via Yahoo Finance· 2 days agoVertex (VRTX) signs a collaboration agreement with TreeFrog to utilize the latter's C-Stem...
Brokers Set Expectations for Vertex Pharmaceuticals Incorporated’s Q3 2025 Earnings (NASDAQ:VRTX)
ETF DAILY NEWS· 1 day agoVertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) – Equities research analysts at Zacks Research cut their Q3 2025 EPS estimates for shares of Vertex Pharmaceuticals ...
Vertex Pharmaceuticals Just Made 2 Big Moves. Is the Stock a Buy?
Motley Fool via Yahoo Finance· 2 days agoVertex Pharmaceuticals (NASDAQ: VRTX) has long been known for its expertise in treating cystic...
Missed Out on Novo Nordisk? 2 Healthcare Stocks With Big Catalysts on the Horizon.
Motley Fool via Yahoo Finance· 21 hours agoHere are two healthcare stocks with big catalysts on the horizon. 1. Vertex Pharmaceuticals Vertex...
Vertex Pharmaceuticals (VRTX) Gains As Market Dips: What You Should Know
Zacks via Yahoo Finance· 5 days agoVertex Pharmaceuticals (VRTX) closed the most recent trading day at $394.28, moving +0.2% from the...
If You'd Invested $10,000 in Vertex Pharmaceuticals 5 Years Ago, Here's How Much You'd Have Today
Motley Fool via Yahoo Finance· 3 days agoVertex Pharmaceuticals (NASDAQ: VRTX) has been through some ups and downs over the past few years....
Is Vertex Pharmaceuticals Stock a Millionaire Maker?
Motley Fool via Yahoo Finance· 6 days agoVertex Pharmaceuticals (NASDAQ: VRTX) is a growing pharmaceutical company with a robust cystic fibrosis (CF) business that generated nearly $10 billion...
Does This Acquisition Make Vertex Pharmaceuticals Stock a Buy?
Motley Fool via Yahoo Finance· 7 days agoBiotech giant Vertex Pharmaceuticals (NASDAQ: VRTX) continues to grab headlines. Over the past six...
Vertex Pharmaceuticals (NASDAQ:VRTX) PT Raised to $450.00
ETF DAILY NEWS· 5 days agoVertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its target price lifted by equities research analysts at Guggenheim from $445.00 to $450.00 in a research note issued ...
VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO OPTIMIZE...
Morningstar· 2 days agoVertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and TreeFrog Therapeutics today announced that Vertex has obtained an exclusive license to TreeFrog's proprietary cell manufacturing ...